Drug-drug interaction with two different route of admi­nistration [Design Issues]

posted by Mr.Rao – India, 2022-07-27 10:31 (1073 d 06:55 ago) – Posting: # 23182
Views: 3,800

Dear All,

from below reference link they are concluded there is no clinically relevant drug–drug interaction between CHF 5993 and result of cimetidine co-administration, with total exposure increased by 16 %, and peak concentration by 26 %.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340825/


I need to know how they concluded.

Looking forward to hear in details.


Thansk,


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! Why didn’t you ignore Ohlbe’s note? [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,678 registered users;
35 visitors (0 registered, 35 guests [including 7 identified bots]).
Forum time: 17:27 CEST (Europe/Vienna)

Half the harm that is done in this world
Is due to people who want to feel important.    T. S. Eliot

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5